Ready-to-go nucleic acid production process
The platform incorporates DNA and RNA manufacturing together with formulation, along with critical reagent supply to address the numerous challenges involved when developing mRNA-based vaccines or therapeutics, from sequence design up to commercial production (e.g., 100 million doses of vaccines)
Ready-to-go nucleic acid production process
The platform incorporates DNA and RNA manufacturing together with formulation, along with critical reagent supply to address the numerous challenges involved when developing mRNA-based vaccines or therapeutics, from sequence design up to commercial production (e.g., 100 million doses of vaccines)
Capitalize on exoREADY process
Nucleic acid
dedicated platform
- EProprietary technology platform
- EDedicated to manufacturing of DNA, RNA and LNPs
- ECan be used at every step of your journey: from discovery up to GMP manufacturing
Nfinity™ equipment
Nplify™ | Ntensify™
- ENew industry gold standard in RNA manufacture
- EEngineering principles of intensification and chaining for highest quality product
- ESingle small footprint system that integrates all process steps accelerating product development
- EHigh quality at high speed, consistent and multiple purposes production equipment
Ready to use
technology
- EPre-developed analytical toolkit
- EReagent premixes for improved production and higher yields
- EIn vivo validated with multiple RNA constructs to de-risk your product development
Get faster to the clinical phase without compromising quality
We go from antigen definition to 1st R&D batch production in less than five months
Get faster to the clinical phase without compromising quality
